Chargement en cours...
Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
A 62-year-old presents with angina. He has been genotyped for a panel of drug metabolism enzymes through a direct-to-consumer genetics company. His results reveal a CYP2C19 *2/*2 genotype with a warning that poor metabolizers (PMs) may have “lack of therapeutic effect of clopidogrel (Plavix), result...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3235907/ https://ncbi.nlm.nih.gov/pubmed/21270785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2010.316 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|